Rare diseases
Investigational molecules
Locations
Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
ItalyStudy on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
ItalyLong-term Safety and Efficacy Study of Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome
ItalyStudy of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors
ItalyStudy of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation
ItalyStudy on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients
ItalyStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
ItalyStudy of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer
ItalyStudy Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells
ItalyStudy on the Safety and Effects of BMS-986507 with Pembrolizumab and Osimertinib Mesylate in Adults with Advanced Solid Tumors
ItalyStudy of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ItalyStudy of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
